Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: Impact on glucose tolerance and β-cell function

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 6, 2004, Pages 2846-2851

  Xiang, Anny H ^a   Peters, Ruth K ^a   Kjos, Siri L ^a   Goico, Jose ^a   Ochoa, Cesar ^a   Marroquin, Aura ^a   Tan, Sylvia ^a   Hodis, Howard N ^a   Azen, Stanley P ^a   Buchanan, Thomas A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GNH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; INSULIN; PLACEBO; TROGLITAZONE;

ADULT; CELL FUNCTION; CENTRAL AMERICA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EVOLUTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEALTH STATUS; HIGH RISK PATIENT; HISPANIC; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; OPEN STUDY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; BLOOD GLUCOSE; CHROMANS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 2942640242     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032044     Document Type: Conference Paper

References (22)

1. American Diabetes Association 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
2. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP 2002 Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2769-2803
3. Buchanan TA, Metzger BE, Freinkel N, Bergman RN 1990 Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162:1008-1014
4. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA 1999 Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48:848-854
5. Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK 1999 Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes 48:2430-2436
6. Buchanan TA, Xiang A, Kjos SL 1998 Gestational diabetes mellitus: antepartum metabolic characteristics that predict postpartum glucose intolerance and type 2 diabetes. Diabetes 47:1302-1310
7. Azen SP, Peters R, Berkowitz K, Kjos S, Xiang A, Buchanan TA 1998 TRIPOD: a randomized placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin Trials 19:217-231
8. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro MN, Buchanan TA 1995 Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 44:586-591
9. Pacini G, Bergman RN 1986 MINMOD, a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23: 113-122
10. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte Jr D 1976 Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42:222-229
11. Kjems LL, Kirby BM, Welsh EM, Veldhuis JD, Straume M, McIntyre SS, Yang D, Lefebvre P, Butler PC 2001 Decrease in β-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50:2001-2012
12. Vague P, Moulin J-P 1982 The defective glucose sensitivity of the B-cell in noninsulin dependent diabetes: improvement after twenty hours of normoglycemia. Metabolism 31:139-142
13. Bergman RN 1989 Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:1512-1527
14. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte Jr D 1993 Quantification of the relationship between insulin sensitivity and B-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672
15. Buchanan TA, Xiang AH, Peters RK, 2000 Response of pancreatic B-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes 49:782-788
16. Colagiuri S, Cull CA, Holman RR, UKPDS Study Group 2003 Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Diabetes Care 25:1410-1417
17. UKPDS Study Group 1998 Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853
18. UKPDS Study Group 1998 Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 352:854-865
19. UKPDS Study Group 1995 Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258
20. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 B-cell deficit and increased B-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
21. Diabetes Prevention Program Research Group 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
22. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350